Using mRNA technology to arm the immune system against HIV
Development of mRNA vaccines has opened a brand-new tool for researchers to use in the...
Learn MoreDevelopment of mRNA vaccines has opened a brand-new tool for researchers to use in the...
Learn MoreThe CTN’s HIV and Aging Cohort Study aims to understand how HIV can affect the development of heart disease, and what can be done to address it
Learn MoreThe CTN 334: Sex Now/Test Now 2022 team is hitting the streets at Pride festivals across Canada to better understand the health and wellbeing of the GBT2Q community
Learn MoreUnderstanding COVID-19 vaccine confidence in people living with HIV in Canada
Learn MoreTo mark International Women’s Day, we sat down with the CTN 335 investigators to learn about how their research could improve healthy aging for women living with HIV
Learn MoreThe drug works against CMV, a common virus that may be a main cause of inflammation and health problems in people living with HIV
Learn MoreAhead of World Cancer Day, we spoke with Dr. Troy Grennan about anal cancer screening among gbMSM living with HIV, a population disproportionately affected by the condition
Learn MoreIn recognition of Bell Let’s Talk Day, we look at what steps can be taken to improve mental health and wellbeing among people affected by HIV
Learn MoreCTN 300: The Engage Study is investigating the use of PrEP among urban Canadian gay, bisexual, and other men who have sex with men
Learn More